We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
84 hedge funds and large institutions have $1.01B invested in Puma Biotechnology in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
79.12% more ownership
Funds ownership: 0% → 79.12% (+79%)
Holders
84
Holders Change
+84
Holders Change %
–
% of All Funds
2.74%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
84
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RFC
76
Russell Frank Company
Seattle,
Washington
| $208K | +$166K | +4,698 | New |
|
|
HTA
77
Haber Trilix Advisors
Boston,
Massachusetts
| $97K | +$77.2K | +2,190 | New |
|
78
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $80K | +$64.2K | +1,820 | New |
|
79
Barclays
London,
United Kingdom
| $52K | +$40.9K | +1,161 | New |
|
|
MAA
80
Managed Account Advisors
Jersey City,
New Jersey
| $45K | +$35.4K | +1,004 | New |
|
81
BlackRock
New York
| $25K | +$19.5K | +553 | New |
|
82
Wells Fargo
San Francisco,
California
| $10K | +$7.93K | +225 | New |
|
|
TRCT
83
Tower Research Capital (TRC)
New York
| $5K | +$3.63K | +103 | New |
|
84
Loomis, Sayles & Company
Boston,
Massachusetts
| $1.31K | +$1.04M | +29,616 | New |
|